Despite being easy and inexpensive to treat, a group of common bacterial and parasitic infections kill hundreds of thousands of people in tropical countries each year. In a new paper, Yale SOM’s Teresa Chahine and her co-authors map the complex system of stakeholders surrounding the diseases and identify key leverage points for making progress.
The story of EHRs serves as a prelude to what we’re experiencing today in almost every facet of our lives: a utopian promise of ubiquitous data tempered by technical challenges and concerns over privacy.
After patients are treated at in-network hospitals, they often receive large, unexpected bills from out-of-network doctors. A new study finds that out-of-network charges from anesthesiologists, pathologists, radiologists, and assistant surgeons increase spending by $40 billion annually.
A new study led by Yale SOM’s Arthur J. Swersey, using decision analysis techniques, finds that increasing the number of biopsy needles and using probability modeling to analyze the results can help prevent unnecessary treatment while identifying dangerous cancers.
This month, the Trump administration announced a series of steps to overhaul the kidney transplant system. We asked operations expert Vahideh Manshadi if the changes could make a difference for patients.
A recent lawsuit alleged that a billionaire investor bought the rights to a new drug just to eliminate a potential competitor. We asked Yale SOM's Florian Ederer to explain why a "catch-and-kill" merger can be damaging and what to do about the phenomenon.